These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2119485)

  • 1. EPO--one year later. Part II. Balancing the costs and benefits.
    Blagg C
    Nephrol News Issues; 1990 Jun; 4(6):22, 38. PubMed ID: 2119485
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaemia management prior to dialysis: cardiovascular and cost-benefit observations.
    Collins AJ
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii2-6. PubMed ID: 12819293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Costs of chronic dialysis in a public hospital: myths and realities].
    Lamas J; Alonso M; Saavedra J; García-Trío G; Rionda M; Ameijeiras M
    Nefrologia; 2001; 21(3):283-94. PubMed ID: 11471309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant erythropoietin. The effect of the marketplace on socialized patient care.
    Besarab A; Erslev AJ
    ASAIO J; 1993; 39(2):85-6. PubMed ID: 8324265
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative aspects of the cost/benefits ratio in dialysis-transplant].
    Guzzanti E; Picca S
    Minerva Chir; 1989 Feb; 44(4):793-800. PubMed ID: 2497406
    [No Abstract]   [Full Text] [Related]  

  • 6. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
    Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
    Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of dialysis treatments for patients with end-stage renal disease in France.
    Jacobs C
    Nephrol Dial Transplant; 1997; 12 Suppl 1():29-32. PubMed ID: 9075226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Financial incentives and dialysis].
    Keller F; Dress H; Mertz A; Marckmann G
    Med Klin (Munich); 2007 Aug; 102(8):659-64. PubMed ID: 17694285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPO--one year later. NRAA survey shows demand for documentation slowing EPO payments. National Renal Administrators Association.
    Messana A
    Nephrol News Issues; 1990 Jun; 4(6):24-5. PubMed ID: 2402307
    [No Abstract]   [Full Text] [Related]  

  • 11. HCFA: failing to acknowledge the unique characteristics of the ESRD patient.
    Kanter A; Nidetz M
    Nephrol News Issues; 1990 Feb; 4(2):23-6, 31. PubMed ID: 2320135
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of dialysis in Canada.
    Prichard SS
    Nephrol Dial Transplant; 1997; 12 Suppl 1():22-4. PubMed ID: 9075224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin & ESRD payments: a promising policy outcome?
    Roe W
    Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost of clinical dialysis--a historical perspective.
    Attrill E; Johnson HK
    Semin Nephrol; 2000 Nov; 20(6):523-5. PubMed ID: 11111853
    [No Abstract]   [Full Text] [Related]  

  • 16. Angio and peritoneal access for endstage renal disease in the community hospital: a cost analysis.
    Chapman JE; Sinicrope RA; Clark DM
    Am Surg; 1986 Jun; 52(6):315-9. PubMed ID: 3717777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPO--one year later: a look at rehabilitation. Does EPO impact on rehabilitation of the dialysis patient? A nursing perspective.
    Stevenson K; Binkley LS
    Nephrol News Issues; 1990 Jun; 4(6):30-1. PubMed ID: 2402309
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal transplantation without dialysis: better results at a lower cost?
    John GT; Viswanathan S
    Natl Med J India; 2001; 14(4):224. PubMed ID: 11547530
    [No Abstract]   [Full Text] [Related]  

  • 20. EPO and renal nutrition--one year later. Evidence lacking in appetite improvement.
    Ellis PW
    Nephrol News Issues; 1990 Jun; 4(6):26, 29, 38. PubMed ID: 2402308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.